| Keywords: |
mitogen activated protein kinase; cancer survival; leukemia; acute granulocytic leukemia; cancer risk; nonhuman; neoplasms; cell proliferation; biological marker; animals; gene; cell division; imatinib; disease association; gene overexpression; thrombocyte; clinical assessment; transcription factor; cell differentiation; chronic myeloid leukemia; gene expression regulation; rna-binding proteins; engraftment; rna, messenger; stem cells; short survey; chromosome translocation; erythrocyte; upregulation; trans-activators; hematopoietic stem cell; cyclin d1; repressor proteins; rna, neoplasm; drosophila proteins; transcription factor hoxa10; transcription factor hoxa9; musashi 2 gene
|
